Status:
COMPLETED
Strategies to Avoid Returning to Smoking
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking
Eligibility:
FEMALE
14+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the relative efficacy of a postpartum smoking relapse prevention program, Strategies to Avoid Returning to Smoking (STARTS), and a supportive, nondirective com...
Detailed Description
The goal of the proposed investigation is to determine whether a cognitive behavioral relapse prevention intervention designed to address mood and weight concerns during the postpartum period will dec...
Eligibility Criteria
Inclusion
- Women will be eligible to participate if they:
- report having smoked daily for at least one month during the 3 months prior to becoming pregnant;
- smoked at least 10 cigarettes per day before quitting;
- report no smoking in the four weeks prior to enrollment;
- are not currently smoking as verified by a CO less than 8ppm;
- are at least 'somewhat' motivated to remain abstinent postpartum and
- are at least 14 years of age.
Exclusion
- Women with current, acute psychiatric disorders, including other substance use problems and symptoms that warrant immediate treatment will be referred for care and excluded from this trial.
- Women with psychiatric disorders (e.g., depressive or anxiety disorders), who are not acutely suicidal and in whom the symptoms are not severe enough to preclude participation in a randomized trial, will be eligible to participate. However, women taking psychiatric medications that may affect the mediators of treatment, such as antidepressant, anxiolytic or weight control medications, will be excluded from participation.
- Women who endorse current suicidality will be discussed immediately with the consulting physician and referred to the psychiatric emergency room for further evaluation as indicated.
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00757068
Start Date
September 1 2007
End Date
June 1 2014
Last Update
May 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC
Pittsburgh, Pennsylvania, United States, 15213